Aiko Omori

Title: Aiko Omori: Innovator in Quinazoline Derivatives

Introduction

Aiko Omori is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit tyrosine kinases. Her work is crucial in advancing treatments for various diseases.

Latest Patents

Aiko Omori holds a patent for "Quinazoline derivatives having tyrosine kinase inhibitory activity." This innovative compound is designed to inhibit both EGF receptor tyrosine kinase and HER2 tyrosine kinase. The patent describes a compound represented by a specific general formula, which includes various substituents and functional groups that enhance its therapeutic potential. The compound's pharmaceutically acceptable salt or solvate is also included in the patent.

Career Highlights

Aiko Omori is associated with Shionogi & Company Limited, a leading pharmaceutical company. Her work at Shionogi has allowed her to focus on developing innovative solutions in the medical field. With her expertise, she has contributed to the advancement of drug development processes.

Collaborations

Aiko has collaborated with notable colleagues, including Masaharu Kume and Kenji Matsuo. These partnerships have fostered a collaborative environment that enhances research and innovation within the company.

Conclusion

Aiko Omori's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a key inventor. Her work continues to impact the development of effective treatments for various medical conditions.